Lillian S.
Grossbard

Ms. Grossbard’s representative matters include:

Antitrust Litigation

• Representing the Blue Cross Blue Shield Association (“BCBSA”) and more than a dozen member plans in consolidated multidistrict antitrust class action litigation—one of the largest class actions in the country—alleging that the Association and its members have used the Association’s agreements to fix prices and limit competition. She also represents BCBSA and various member plans in related opt-out litigation across the country brought by large subscribers and providers.
• Represented Biosense Webster (a Johnson & Johnson subsidiary) in antitrust litigation brought by competitor Innovative Health alleging monopolization and restraint of trade in the nationwide market for the sale of high‑density mapping and ultrasound catheters. Ms. Grossbard helped secure a summary judgment victory for Biosense.
• Represented Time Warner in an antitrust lawsuit brought by the DOJ seeking to block the company’s $109 billion sale to AT&T, securing a victory in June 2018 following a six‑week trial.
• Represented Anheuser‑Busch InBev (“ABI”) in winning the dismissal of a consumer antitrust suit filed in Oregon federal court challenging ABI’s $123 billion acquisition of SABMiller plc and the $12 billion divestiture of SABMiller’s U.S. and global Miller‑branded businesses to Molson Coors Brewing Company.
• Represented American Express in a consumer class action litigation alleging that American Express had conspired with other credit card issuers to adopt arbitration clauses barring class actions in card member agreements, securing a victory following a five‑week bench trial.

Regulatory Clearance

• Advised Stanley Black & Decker on antitrust issues in connection with its $1.95 billion acquisition of the tools business of Newell Brands Inc.
• Advised Weyerhaeuser Company on antitrust issues in connection with the $2.2 billion sale of its Cellulose Fibers pulp mills to International Paper Company.
• Advised Grupo Villar Mir on antitrust issues in connection with its merger with Globe Specialty Metals, Inc. with an enterprise value of approximately $3.1 billion.

Select Additional Representations

• Represented Costamare Shipping and related entities in connection with litigation filed in California federal court, including a consolidated putative class action, alleging various theories of liability concerning the October 2021 San Pedro Bay pipeline leak off the coast of California—ultimately securing a series of settlements to resolve the actions.
• Represented PG&E in hundreds of lawsuits, including numerous putative class actions, filed against the company arising out of the unprecedented 2017 and 2018 California wildfires—one of the largest and most complex sets of mass tort litigation in recent years—and helped to steer the company through the largest utility bankruptcy in U.S. history.
• Represented Biogen in a qui tam action alleging that Biogen caused the submission of false claims to multiple federal healthcare programs through purported kickback schemes related to certain of Biogen’s multiple sclerosis drugs, which settled.
• Advised the compliance monitor for TK Holdings (“Takata”) regarding process safety matters in connection with the recall of certain of Takata’s ammonium nitrate airbag inflators.
• Represented Credit Suisse in multiple residential mortgage-backed securities litigation, eliminating billions of dollars in claims against the company.

Ms. Grossbard was born in Englewood, New Jersey. She received a B.A. cum laude from Smith College in 1991, and a J.D. from Fordham University School of Law in 1997, where she was elected to the Order of the Coif and was a member of the Law Review. Ms. Grossbard joined Cravath in 1997 and was elected a partner in 2023.